Shares in Dr Martens (LSE:DOCS), the FTSE 250 bootmaker, crashed 19% on 20 September after it was reported that a group of investors had collectively sold approximately 7.3% of the company, at a 9.8% discount (57.85p) to the prevailing market price.
Until news of the placing was released, the share price had never been below 63p. So unless these shareholders invested before the company listed on the stock market, I suspect most of them have taken a large loss.
Although the stock has recovered a little since, the result of this turbulence is that the British legend’s market cap is now (25 September) only £515m.
And a look at its balance sheet at 31 March 2024, suggests this could be something of a bargain.
Loads of stock
That’s because at this date, the company held stock of £254.6m which is ready to be turned into cash.
Accounting standards require inventories to be included in financial statements at the lower of cost and net realisable value.
We know from the accounts for the year ended 31 March 2024 (FY24), that Dr Martens made a gross profit margin of 65.6%. If this were to continue, it means £254.6m of stock would generate £485.5m of gross profit.
Measure
Projected
Revenue (£m)
740.1
Inventories at cost (£m)
254.6
Gross profit (£m)
485.5
Gross profit percentage (%)
65.6
Source: company accounts and author’s calculations
In other words, the company’s now valued at only 6% more than the earnings (before overheads) that its stock should generate.
In fact, the position is probably even better. I suspect most of the costs incurred in producing this stock have already been invoiced by suppliers and paid. In cash terms, it’s therefore worth £740.1m.
Other considerations
Of course, this is rather simplistic. A company isn’t valued on one asset alone. There are also liabilities that need to be taken into account.
And earnings are important too.
In April, it warned that its FY25 profit before tax could be one-third of its FY24 level. This means earnings per share might be as low as 2.3p. Even at its current share price, the stock’s trading on a forward multiple of 23.6. On this basis, it’s not cheap.
All this illustrates how much investors appear to have fallen out of love with the company.
And the level of stock points to a wider problem.
Due to lower than expected sales, particularly in the US, the company’s inventory has been higher than anticipated.
At 31 March 2024, it was carrying the equivalent of 44 weeks of product sales in stock. For comparison, at 28 April 2024, Frasers Group had 22 weeks of inventory on its balance sheet.
As well as tying up cash, there are warehousing costs involved in holding too many goods for resale.
My view
With its strong brand and global appeal, I’m optimistic that the performance of Dr Martens will start to improve.
And the company’s doing everything I’d expect in a turnaround situation. Actions include changing its leader, addressing its stock issue and reinvigorating its marketing. It’s also reduced its dividend.
But despite its shares being close to an all-time low, I don’t want to include it in my portfolio. The stock’s too risky for me.
I’d need to see the green shoots of a recovery before parting with my cash.
The post After falling 14% in a week, is this FTSE 250 stock the bargain of the century? appeared first on The Motley Fool UK.
5 Shares for the Future of Energy
Investors who don’t own energy shares need to see this now.
Because Mark Rogers — The Motley Fool UK’s Director of Investing — sees 2 key reasons why energy is set to soar.
While sanctions slam Russian supplies, nations are also racing to achieve net zero emissions, he says. Mark believes 5 companies in particular are poised for spectacular profits.
Open this new report — 5 Shares for the Future of Energy — and discover:
Britain’s Energy Fort Knox, now controlling 30% of UK energy storage
How to potentially get paid by the weather
Electric Vehicles’ secret backdoor opportunity
One dead simple stock for the new nuclear boom
Click the button below to find out how you can get your hands on the full report now, and as a thank you for your interest, we’ll send you one of the five picks — absolutely free!
Grab your FREE Energy recommendation now
More reading
I’m avoiding these FTSE ‘value’ stocks like the plague!
With its share price crashing 87% in less than 4 years, is this now a bargain basement growth stock?
It’s near a 52-week low, but I wouldn’t touch this FTSE 250 stock with a bargepole!
Is now the time to buy these 3 FTSE 250 British legends that have fallen on hard times?
Here’s how I’d invest £1,000 in a Stocks and Shares ISA in September
James Beard has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.
